By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ChromaDex, Inc. 

10005 Muirlands Boulevard
Suite G, First Floor
Irvine  California  92618  U.S.A.
Phone: 949-419-0288 Fax: 949-419-0294



Company News
A Letter From The ChromaDex, Inc. Chief Executive Officer 2/23/2017 8:33:44 AM
ChromaDex, Inc. Release: Study Published In PAIN Reveals Nicotinamide Riboside Is An Effective Tool In Relieving Chemotherapy-Induced Peripheral Neuropathy Induced By A Common Anticancer Agent 2/22/2017 10:25:16 AM
ChromaDex, Inc. Opens New State-of-the-Art Research And Development Center In Longmont 1/5/2017 10:41:15 AM
California Biotech ChromaDex, Inc. to Set Up New R&D Plant in Longmont 12/27/2016 7:12:56 AM
ChromaDex, Inc. Release: U.S. FDA Issues GRAS No Objection Letter For NIAGEN 8/16/2016 12:20:06 PM
ChromaDex, Inc. Vindicated By Retraction And Apology From Author Of Misleading And Factually Inaccurate Article 6/30/2016 1:49:43 PM
ChromaDex, Inc. Added To The Russell 2000 Index 6/28/2016 11:41:21 AM
ChromaDex, Inc. Release: University Researchers Show Vitamin Nicotinamide Riboside Is An Effective Tool For Managing The Negative Effects Of Obesity And Diabetes 6/1/2016 8:16:21 AM
ChromaDex, Inc. Announces Reverse Stock Split As Company Seeks To List Its Common Stock On The NASDAQ Capital Market 4/13/2016 8:11:14 AM
ChromaDex, Inc. Announces Commencement Of An Obesity-Related Clinical Study Of NIAGEN In Collaboration With The University of Copenhagen And Aarhus University 2/22/2016 11:50:11 AM